Brief report: Impaired in vivo neovascularization capacity of endothelial progenitor cells in patients with systemic sclerosis

Arthritis and Rheumatology

Volumn 66, Issue 5, 2014, Pages 1300-1305

  Kuwana, Masataka ^a   Okazaki, Yuka ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL; BLOOD VESSEL WALL; CARCINOMA CELL; CELL COUNTING; CELL SELECTION; CLINICAL ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; TUMOR GROWTH; TUMOR VOLUME;

ADULT; ANIMALS; ANTIGENS, CD; ANTIGENS, CD34; CASE-CONTROL STUDIES; CELL COUNT; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; GLYCOPROTEINS; HETEROGRAFTS; HUMANS; MALE; MICE; MICE, SCID; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES; SCLERODERMA, SYSTEMIC; STEM CELLS;

EID: 84899722753     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38326     Document Type: Article

References (15)

1. Kuwana M, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y,. Defective vasculogenesis in systemic sclerosis. Lancet 2004; 364: 603-10.
2. Urbich C, Dimmeler S,. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004; 95: 343-53.
3. Kuwana M, Okazaki Y,. Quantification of circulating endothelial progenitor cells in systemic sclerosis: a direct comparison of protocols. Ann Rheum Dis 2012; 71: 617-20.
4. Avouac J, Wipff J, Goldman O, Ruiz B, Couraud PO, Chiocchia G, et al. Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions. Arthritis Rheum 2008; 58: 3550-61.
5. Distler JH, Allanore Y, Avouac J, Giacomelli R, Guiducci S, Moritz F, et al. EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Ann Rheum Dis 2009; 68: 163-8.
6. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
7. Kuwana M, Okazaki Y, Kodama H, Satoh T, Kawakami Y, Ikeda Y,. Endothelial differentiation potential of human monocyte-derived multipotential cells. Stem Cells 2006; 24: 2733-43.
8. Prater DN, Case J, Ingram DA, Yoder MC,. Working hypothesis to redefine endothelial progenitor cells. Leukemia 2007; 21: 1141-9.
9. Yamaguchi Y, Okazaki Y, Seta N, Satoh T, Takahashi K, Ikezawa Z, et al. Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis. Arthritis Res Ther 2010; 12: R205.
10. Avouac J, Cagnard N, Distler JH, Schoindre Y, Ruiz B, Couraud PO, et al. Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells. Arthritis Rheum 2011; 63: 3552-62.
11. Richardson MR, Yoder MC,. Endothelial progenitor cells: quo vadis? J Mol Cell Cardiol 2011; 50: 266-72.
12. Del Papa N, Quirici N, Soligo D, Scavullo C, Cortiana M, Borsotti C, et al. Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum 2006; 54: 2605-15.
13. Carrai V, Miniati I, Guiducci S, Capaccioli G, Alterini R, Saccardi R, et al. Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis. Rheumatology (Oxford) 2012; 51: 1042-8.
14. Guiducci S, Manetti M, Romano E, Mazzanti B, Ceccarelli C, Dal Pozzo S, et al. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro. Ann Rheum Dis 2011; 70: 2011-21.
15. Cipriani P, Marrelli A, Benedetto PD, Liakouli V, Carubbi F, Ruscitti P, et al. Scleroderma mesenchymal stem cells display a different phenotype from healthy controls: implications for regenerative medicine. Angiogenesis 2013; 16: 595-607.